Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current HIV Research
  4. Volume 22, Issue 5
  5. Article
Volume 22, Issue 5
  • ISSN: 1570-162X
  • E-ISSN: 1873-4251

Abstract

Background

Diagnosis for HIV in infants is hard to determine, particularly in limited-resource areas. A delay in the diagnosis of HIV-infected infants will lead to high morbidity and mortality. The purpose of this project is to construct a model of an HIV-positive infant and develop a useful and practical scoring system to estimate the likelihood of mother-to-child transmission that can be applied in the field.

Methods

A cross-sectional study on 100 subjects through medical records of infants born to HIV-infected mothers was conducted at four hospitals and one community health center. Several models of risk prediction scores of HIV-infected infants were then made. Furthermore, the performed validation was performed on 20 subjects of infants born to mothers with HIV in three hospitals by comparing the scoring system and the result of the PCR RNA examination performed at the age of 6 weeks old.

Results

The risk of HIV-infected infants was higher in mothers who did not receive ARV through PMTCT programs (OR 33.6; 95% CI 4.0 to 282.2), pulmonary TB infection (OR 5.1; IK95% 1.6 to 16.0) and vaginal delivery (OR 9.2; IK95 2.2 to 38.0%). Two models can predict the occurrence of infected HIV infants effectively. Model 1 consists of maternal age, maternal ARVs, lung TB infection, gestational age, mode of delivery, and sex of the infants with sensitivity and specificity of 78.9% and 70.8% (AUC=0.817 [95% CI 0.709 to 0.926]) and likelihood ratio score of 4. Model 2 consists of ARVs to the mother, pulmonary TB infection, and mode of delivery with sensitivity and specificity of 73.7% and 86.1%; AUC value of 0.812 (95% CI 0.687 to 0.938) and likelihood ratio of 5. External Validation gave similar results to the Model 2 scoring system with PCR RNA.

Conclusion

The prediction score of HIV-infected infants in Model 2 can be used in newborns of HIV-positive mothers as an effective and practical risk screening tool for HIV-infected infants before the gold standard examination by PCR.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/chr/10.2174/011570162X304984240822052915
2024-08-29
2025-01-10

  • From This Site

    /content/journals/chr/10.2174/011570162X304984240822052915
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Joint United Nations Program on HIV/AIDS.UNAIDS Report on the global AIDS epidemic 2014.GenevaWorld Health Organization2015
     [Google Scholar]
  2. Joint United Nations Program on HIV/AIDS.UNAIDS Report on the global AIDS epidemic 2012.GenevaWorld Health Organization2013
     [Google Scholar]
  3. Joint United Nations Program on HIV/AIDS.UNAIDS Report on the global AIDS epidemic 2010.GenevaWorld Health Organization2011
     [Google Scholar]
  4. UNAIDS epiedemiological estimates.2022Available from:aidsinfo.unaids.org(accessed on 7-8-2024)
  5. HIV and AIDS Data Hub for Asia-Pacific.2013Available from:fromwww.aidsdatahub.org(accessed on 7-8-2024)
  6. HIV and AIDS Data Hub for Asia-Pacific. Evidence to Action: Indonesia review 2022.2022
     [Google Scholar]
  7. DitjenPP Statistik kasus HIV/AIDS di Indonesia tahun 2014.2014
     [Google Scholar]
  8. Ditjen Pencegahan & Pengendalian Penyakit Kemkes RI Perkembangan HIV AIDS dan Penyakit Infeksi Menular Seksual tahun 2022.Kemkes2022
     [Google Scholar]
  9. CooperE.R. CharuratM. MofensonL. HansonI.C. PittJ. DiazC. HayaniK. HandelsmanE. SmeriglioV. HoffR. BlattnerW. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.J. Acquir. Immune Defic. Syndr.200229548449410.1097/00042560‑200204150‑0000911981365
     [Google Scholar]
  10. LallemantM. JourdainG. Le CoeurS. MaryJ.Y. Ngo-Giang-HuongN. KoetsawangS. KanshanaS. McIntoshK. ThaineuaV. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.N. Engl. J. Med.2004351321722810.1056/NEJMoa03350015247338
     [Google Scholar]
  11. WHO recommendations on the therapy of HIV infection in infants and children 2010.SwitzerlandWHO2010
     [Google Scholar]
  12. WHO recommendations on the therapy of HIV infection in infants and children 2021.SwitzerlandWHO2021
     [Google Scholar]
  13. ScottG.B. HuttoC. MakuchR.W. MastrucciM.T. O’ConnorT. MitchellC.D. TrapidoE.J. ParksW.P. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection.N. Engl. J. Med.1989321261791179610.1056/NEJM1989122832126042594038
     [Google Scholar]
  14. ShermanG.G. CooperP.A. CoovadiaA.H. PurenA.J. JonesS.A. MokhachaneM. BoltonK.D. Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings.Pediatr. Infect. Dis. J.2005241199399710.1097/01.inf.0000187036.73539.8d16282936
     [Google Scholar]
  15. GinsburgA.S. MillerA. WilfertC.M. Diagnosis of pediatric human immunodeficiency virus infection in resource-constrained settings.Pediatr. Infect. Dis. J.200625111057106410.1097/01.inf.0000243157.16405.f017072130
     [Google Scholar]
  16. Joint United Nations Program on HIV/AIDS.UNAIDS report on the global AIDS epidemic 2009.GenevaWHO2011
     [Google Scholar]
  17. Kovacs A. HIV disease progression and antiretroviral therapy initiation in infants/children.2004 Available from: www.medscape.com(accessed on 7-8-2024)
  18. AbramsE.J. MathesonP.B. ThomasP.A. TheaD.M. KrasinskiK. LambertG. ShafferN. BamjiM. HutsonD. GrimmK. KaulA. BatemanD. RogersM. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth.Pediatrics199596345145810.1542/peds.96.3.4517651777
     [Google Scholar]
  19. CollinsI.J. JourdainG. HansudewechakulR. KanjanavanitS. HongsiriwonS. NgampiyasakulC. SriminiphantS. TechnakunakornP. Ngo-Giang-HuongN. DuongT. Le CoeurS. JaffarS. LallemantM. Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort study.Clin. Infect. Dis.201051121449145710.1086/65740121054181
     [Google Scholar]
  20. FisherG.R. BoyceT.G. HIV infection and AIDS.Moffet’s Pediatric Infectious Diseases, A problem-oriented approach.4th edPhiladelphiaLippincott Williams & Wilkins2005666689
     [Google Scholar]
  21. ShafferN. RoongpisuthipongA. SiriwasinW. ChotpitayasunondhT. ChearskulS. YoungN.L. ParekhB. MockP.A. BhadrakomC. ChinayonP. KalishM.L. PhillipsS.K. GranadeT.C. SubbaraoS. WenigerB.G. MastroT.D. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand.J. Infect. Dis.1999179359059910.1086/3146419952365
     [Google Scholar]
  22. SrinirundP. Getting to zero: Thailand’s experience with e-MTCT. 20th International AIDS ConferenceMelbourne2014
     [Google Scholar]
  23. GuptaA. BhosaleR. KinikarA. GupteN. BharadwajR. KagalA. JoshiS. KhandekarM. KarmarkarA. KulkarniV. SastryJ. MaveV. SuryavanshiN. ThakarM. KulkarniS. TripathyS. SambareyP. PatilS. ParanjapeR. BollingerR.C. JamkarA. Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus.J. Infect. Dis.2011203335836210.1093/jinfdis/jiq06421208928
     [Google Scholar]
  24. BeasleyR.P. TrepoC. StevensC. SzmunessW. The e antigen and vertical transmission of hepatitis B surface antigen.Am. J. Epidemiol.19771052949810.1093/oxfordjournals.aje.a112370835566
     [Google Scholar]
  25. GibbD.M. GoodallR.L. DunnD.T. HealyM. NeaveP. CafferkeyM. ButlerK. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission.Lancet2000356923390490710.1016/S0140‑6736(00)02681‑711036896
     [Google Scholar]
  26. IoannidisJ.P.A. AbramsE.J. AmmannA. BulterysM. GoedertJ.J. GrayL. KorberB.T. MayauxM.J. MofensonL.M. NewellM.L. ShapiroD.E. TeglasJ.P. WilfertC.M. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.J. Infect. Dis.2001183453954510.1086/31853011170978
     [Google Scholar]
  27. MayauxM.J. BlancheS. RouziouxC. ChenadecJ.L. ChambrinV. FirtionG. AllemonM.C. VilmerE. VigneronN.C. TricoireJ. GuillotF. Maternal factors associated with perinatal HIV-1 transmission: the French Cohort Study: 7 years of follow-up observation.J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.19958218819410.1097/00042560‑199502000‑000107834401
     [Google Scholar]
  28. TorpeyK. MandalaJ. KasondeP. Bryan-MofyaG. BweupeM. MukunduJ. ZimbaC. MwaleC. LumanoH. WelshM. Analysis of HIV early infant diagnosis data to estimate rates of perinatal HIV transmission in Zambia.PLoS One201278e4285910.1371/journal.pone.004285922912752
     [Google Scholar]
  29. Pedoman penerapan terapi hiv pada anak.WHO2014
     [Google Scholar]
/content/journals/chr/10.2174/011570162X304984240822052915
Loading
Prediction Models for HIV Infection in Infants: Analysis of Scoring Systems on Maternal, Infants, and Mode of Delivery Risk Factors
Current HIV Research 22, 329 (2024); https://doi.org/10.2174/011570162X304984240822052915
/content/journals/chr/10.2174/011570162X304984240822052915
/content/journals/chr/10.2174/011570162X304984240822052915
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Drugs; infected HIV infant; infectious pulmonary tuberculosis; mode of delivery; prediction model; scoring models
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test